Chronic Myelogenous Leukemia - Chronic Phase: Clinical Trials

3 trials for Chronic Myelogenous Leukemia - Chronic Phase, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 1 terminated. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Active not recruiting 2, Terminated 1
Phase 11Active not recruiting 1

Follow Chronic Myelogenous Leukemia - Chronic Phase: new trials by email Literature Review of Chronic Myelogenous Leukemia - Chronic Phase trials Research Report on Chronic Myelogenous Leukemia - Chronic Phase

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia
asciminib - Chronic Myelogenous Leukemia - Chronic Phase
Phase 2Active not recruitingNovartis Pharmaceuticals342022-11-112025-10-14
Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation
Vorinostat, Blood and Marrow Transplant (BMT), Tacrolimus (or cyclosporine) - Hematologic Diseases, Acute Leukemia in Remission
Phase 1 / Phase 2Active not recruitingUniversity of Michigan Rogel Cancer Center432020-02-042026-01-27
Study of Molecular Response in Adult Patients on Nilotinib With Philadelphia Chromosome Positive Chronic Myelogenous Leukemia (Ph+ CML) in Chronic Phase and a Suboptimal Molecular Response to Imatinib
Nilotinib - Chronic Myelogenous Leukemia - Chronic Phase
Phase 2TerminatedNovartis Pharmaceuticals182008-10-012021-08-18

Narrower conditions

Leukemia, Myeloid, Chronic-Phase (3)  ·  Blast Crisis (1)  ·  Graft vs Host Disease (1)  ·  Hematologic Diseases (1)  ·  Leukemia (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Leukemia, Myeloid, Accelerated Phase (1)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Myelodysplastic Syndromes (1)

Broader conditions

Bone Marrow Diseases (3)  ·  Chronic Disease (3)  ·  Disease Attributes (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Leukemia, Myeloid (3)  ·  Myeloproliferative Disorders (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Hematologic Diseases (2)  ·  Leukemia (2)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2)  ·  Carcinogenesis (1)  ·  Cell Transformation, Neoplastic (1)

Interventions

Blood Specimen Collection (1)  ·  Cyclophosphamide (1)  ·  Cyclosporine (1)  ·  Methotrexate (1)  ·  Mycophenolic Acid (1)  ·  Tacrolimus (1)  ·  Vorinostat (1)  ·  asciminib (1)  ·  nilotinib (1)

Sponsors

Novartis Pharmaceuticals (2)  ·  University of Michigan Rogel Cancer Center (1)

Countries

United States (3)

Top investigators

Sung W Choi, MD, MS (1)

Results publications

PMID 28042454, PMID 39387441, PMID 42784255

NIH funding

UL1TR002240 (1)